ClinicalTrials.gg
Drug

Insulin Glargine clinical trials

Also written Lantus, Glargine, LY2963016 and Basaglar.

Includes 3 studies of MK-1293 and 1 study of MYL-1501D.

studies test it
294
open now
6
in phase 3
89
first study started
2000

How each study uses Insulin Glargine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Insulin Glargine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Apr 2000 · LANTUS SOLOSTAR · BLA 021081 (FDA, Drugs@FDA)
European Union
9 Jun 2000 · Lantus · EMEA/H/C/000284 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

insulin glargine
135
Toujeo
11
INSULIN GLARGINE (HOE901)
9
INSULIN GLARGINE (U300)
8
Glargine insulin
7

Brand

Lantus
73
Basaglar
8
Toujeo SoloStar
1

Development codes

LY2963016
14
HOE901
4

Other names

Glargine
28

In one entry with another drug

Given together, or one or the other

iGlarLixi
9
Insulin glargine/Lixisenatide (HOE901/AVE0010)
7
Soliqua
4
Insulin glargine/Lixisenatide
3
LixiLan
3
Soliqua 100/33
2
HOE901/AVE0010
2

Biosimilars

Semglee
2
Abasaglar®
1

Studies by the year they started

294 studies that test it; most in 2011 (26)

Studies that test Insulin Glargine, by start year
YearStudies
20001
20018
200211
200316
200414
200515
200616
20078
200812
200917
201021
201126
201218
201311
201413
201516
201612
20178
201810
20199
20205
20214
202210
20234
20245
20253
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
27
Phase 2
5
Phase 3
89
Phase 4
148
No phase
24

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 185 · Other 109

Sanofi (117) · Novo Nordisk A/S (28) · Eli Lilly and Company (25) · Emory University (9) · Merck Sharp & Dohme LLC (4) · Life for a Child Program, Diabetes Australia (3) · Ain Shams University (3) · University of Colorado, Denver (3)

Often tested with

Tested in the same studies.

Insulin glulisine (25) · Metformin (21) · Lixisenatide (20) · Insulin Aspart (17) · Insulin degludec (17) · Insulin Detemir (15) · Insulin Lispro (8) · Insulin, Isophane (8)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Insulin Glargine is the comparator. A study of two new drugs counts under both.

  • 1Insulin icodec · Novo Nordisk A/S · next primary completion Jan 2027
  • 1GZR4 · Gan & Lee Pharmaceuticals.
  • 1Dorzagliatin · University of Alabama at Birmingham
Reaching primary completion within a year · 1

Studies that test Insulin Glargine.

Studies

Open first, then newest update. How each study uses Insulin Glargine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 294

See all 294 studies that test Insulin Glargine →

Given beside what is tested · 74 — Insulin Glargine is usual care or a partner of the new treatment

Showing 20 of 74.

As the comparator · 146 — what is tested is compared with Insulin Glargine

Showing 20 of 146.

Codes

What other systems call Insulin Glargine · ClinicalTrials.gg INT006562

  • MeSH (NLM) D000069036Insulin GlargineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2ZM8CX04RZINSULIN GLARGINEConfirmed FDA, NLM, Wikidata
  • RxNorm 274783Confirmed FDA, Wikidata
  • Wikidata Q417317insulin glargineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47564Insulin GlargineOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.